SAN DIEGO--(BUSINESS WIRE)--Ambit Biosciences announced today the appointment of Wendell Wierenga, Ph.D., as Executive Vice President of Research & Development (R&D). Dr. Wierenga previously served as Executive Vice President of R&D at Neurocrine Biosciences and has been a member of Ambit’s board of directors since 2005.
